Abeona Therapeutics Inc. ABEO
Set alert
4.35 USD 0.00 0.00%
At close
4.35 0.00 0.00%
Pre-market · Nov 2, 8:23 AM ET
4.31 Day range 4.53
4.00 52-week range 7.65
- YTD
- -17.46%
- 1 year
- -14.37%
- Open
- 4.50
- Prev close
- 4.35
- Mkt cap
- 248.75M
- Vol
- 783.43K
- Avg vol
- 1.35M
- EPS
- -1.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.31
- High
- 4.53
- Forward P/E
- -3.84
- Beta
- 1.50
- Short ratio
- 10.79
- Inst. own
- 77.54%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.15
- 200-d avg
- 5.64
- 1y target
- 16.75
5Y chart
Events in this range
- Jul 5, 2022Split: 1 for 25
- Aug 8, 2023Earnings: -0.44; estimate -0.66; surprise 33.33%
- Nov 13, 2023Earnings: -0.48; estimate -0.53; surprise 9.43%
- Mar 18, 2024Earnings: -0.64; estimate -0.51; surprise -25.49%
- May 15, 2024Earnings: -0.53; estimate -0.47; surprise -12.77%
- Jul 3, 2024Rating: HC Wainwright & Co. · — → Buy
- Jul 12, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 12, 2024Earnings: -0.75; estimate -0.33; surprise -127.27%
- Aug 14, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Oct 29, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
- Oct 31, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 14, 2024Earnings: -0.31; estimate -0.38; surprise 18.42%
- Nov 25, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (78)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bullish | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 6, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 9, 2024 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Sep 16, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bullish | Aug 26, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 22, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| RSI: Overbought | Feb 12, 2024 | 2 years ago |
| SMA: Bullish | Feb 5, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 5, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 29, 2024 | 2 years ago |
| SMA: Bearish | Jan 22, 2024 | 2 years ago |
| RSI: Overbought | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Oct 23, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 23, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Aug 21, 2023 | 3 years ago |
| SMA: Bullish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | May 15, 2023 | 3 years ago |
| SMA: Bearish | May 8, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 24, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Mar 20, 2023 | 3 years ago |
| SMA: Bearish | Mar 13, 2023 | 3 years ago |
| SMA: Bullish | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bearish | Oct 17, 2022 | 4 years ago |
| SMA: Bullish | Oct 3, 2022 | 4 years ago |
| RSI: Oversold | Sep 19, 2022 | 4 years ago |
| RSI: Oversold | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Jul 25, 2022 | 4 years ago |
| RSI: Oversold | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jun 27, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Feb 28, 2022 | 4 years ago |
Key statistics
- Market cap
- 246.92M
- Enterprise value
- 158.18M
- Trailing P/E
- 0.00
- Forward P/E
- -3.84
- PEG ratio
- 0.00
- Price / book
- 10.16
- EPS (TTM)
- -2.05
- Beta
- 1.50
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -20.50M
- Total cash
- 122.71M
- Total debt
- 23.16M
- Return on equity
- -127.38%
- Shares outstanding
- 43.47M
- Short % of float
- 6.29%
- 50-day average
- 6.15
- 200-day average
- 5.64
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 16.75 +285.1% upside
Now 4.35
- Target (low)
- 9.50
- Target (mean)
- 16.75
- Target (high)
- 21.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.34.
Financials — quick view
ABEO Revenue — quarterly 11.38M
ABEO Net income — quarterly -20.19M
ABEO EPS — quarterly -0.35
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | -0.38 | -0.31 | +0.07 | +18.42% |
| Aug 12, 2024 | Jun 1, 2024 | -0.33 | -0.75 | -0.42 | -127.27% |
| May 15, 2024 | Mar 1, 2024 | -0.47 | -0.53 | -0.06 | -12.77% |
| Mar 18, 2024 | Dec 1, 2023 | -0.51 | -0.64 | -0.13 | -25.49% |
| Nov 13, 2023 | Sep 1, 2023 | -0.53 | -0.48 | +0.05 | +9.43% |
| Aug 8, 2023 | Jun 1, 2023 | -0.66 | -0.44 | +0.22 | +33.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 31, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 29, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Aug 14, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 12, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 3, 2024 | HC Wainwright & Co. | init | — | Buy |
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- abeonatherapeutics.com
News
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics Inc. (NASDAQ:ABEO) Stock Has Consensus Target Price of $21.00
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
- Abeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. Wainwright
- Abeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum
Your note
Sign in to keep a note on ABEO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLAND LEILA | Director | Stock Award(Grant) | Aug 25, 2024 | 118,265 |
| ALVINO MARK J. | Director | Stock Award(Grant) | Aug 25, 2024 | 72,334 |
| AMOROSO MICHAEL | Director | Stock Award(Grant) | Aug 25, 2024 | 144,365 |
| CHARLES FAITH L. | Director | Stock Award(Grant) | Aug 25, 2024 | 113,731 |
| CROMBEZ ERIC M.D. | Director | Stock Award(Grant) | Aug 12, 2024 | 11,044 |
| O'MALLEY BRENDAN M | General Counsel | Stock Award(Grant) | Jul 7, 2024 | 280,364 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 8.48% | 3,685,503 | 20.93M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 7.90% | 3,432,637 | 19.50M | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 7.48% | 3,249,994 | 18.46M | Sep 29, 2024 |
| Millennium Management Llc | 5.29% | 2,301,628 | 13.07M | Sep 29, 2024 |
| Vanguard Group Inc | 4.62% | 2,007,626 | 11.40M | Sep 29, 2024 |
| Vivo Capital, LLC | 4.24% | 1,842,751 | 10.47M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.84% | 1,232,465 | 7.00M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.62% | 703,062 | 3.99M | Sep 29, 2024 |
| Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF | 0.94% | 408,584 | 2.32M | Sep 29, 2024 |
| abrdn Life Sciences Investors | 0.75% | 326,995 | 1.86M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.53% | 229,139 | 1.30M | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.21% | 89,297 | 507.21K | Oct 30, 2024 |